New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, found that JAK inhibitors (JAKi) and tocilizumab elicited better response rates in VEXAS syndrome compared to other targeted ...
Nov 7, 2023
0
1
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren's become more severe over time and that the ...
Nov 7, 2023
0
20
According to new research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, continuing tumor necrosis factor inhibitors during pregnancy is not associated with worse fetal or obstetric ...
Nov 7, 2023
0
1
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, describes the expansion of a novel program to train primary care physicians (PCPs) in the diagnosis and management of rheumatoid ...
Nov 7, 2023
0
0
For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events, according to a study published online Oct. 12 in The Lancet.
Nov 6, 2023
0
2
Newer oral medications for rheumatoid arthritis (RA) do work quite well in the "real world," despite some doubts that they would, according to a new study.
Nov 4, 2023
0
41
Characterized by extensive damage to joints and debilitating pain, osteoarthritis (OA) impacts millions of people worldwide and has long posed a substantial clinical and economic burden.
Nov 2, 2023
0
38
A health care team has endorsed a new cultural competency training program which could help clinicians better connect with diverse population living with an auto-immune rheumatologic conditions.
Nov 2, 2023
0
7
According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do ...
Nov 1, 2023
0
3
Initial nonsurgical treatment, including the use of orthotics and exercise therapy, provides satisfactory long-term outcomes for patients with osteoarthritis of the thumb carpometacarpal joint (CMC-1 OA), with a low rate ...
Oct 31, 2023
0
1
